Clinical diagnosis and treatment of olfactory dysfunction related to COVID-19: A literature review
Article Sidebar
Main Article Content
Abstract
Introduction: Coronavirus disease 2019 is a pandemic disease that has caused more than six million deaths worldwide. The clinical picture of the infection can vary depending on the severity of the disease and usually includes general, ENT and neurological symptoms. Objective: To provide a narrative review of the scientific literature on the clinical diagnosis and treatment of olfactory dysfunction related to coronavirus disease 2019. Results: Olfactory dysfunction defined as the reduced or distorted ability to smell when inhaling (orthonasal smell) or when eating (postnasal smell), is often reported in mild or even asymptomatic cases. The prevalence
of olfactory dysfunction can vary with respect to the clinical setting, with rates of total loss of smell as high as 70% in patients with mild coronavirus disease 2019. In addition, to date there is a paucity of articles prospectively evaluating recovery rates of olfactory dysfunction in patients with coronavirus disease 2019. Conclusion: Coronavirus disease 2019 is associated with olfactory dysfunction in various
patients. Active and collaborative research is required to delineate the natural history and appropriate management of olfactory dysfunction in this virulent disease. In the meantime, diagnosis and targeted treatments such as olfactory training may be helpful
in olfactory dysfunction related to coronavirus disease 2019.
Article Details
Section
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Este artículo es publicado por la Revista Acta de Otorrinolaringología & Cirugía de Cabeza y Cuello.
Este es un artículo de acceso abierto, distribuido bajo los términos de la LicenciaCreativeCommons Atribución-CompartirIgual 4.0 Internacional.( http://creativecommons.org/licenses/by-sa/4.0/), que permite el uso no comercial, distribución y reproducción en cualquier medio, siempre que la obra original sea debidamente citada.
eISSN: 2539-0856
ISSN: 0120-8411
How to Cite
References
1. Le Bon SD, Konopnicki D, Pisarski N, Prunier L, Lechien JR, Horoi M. Efficacy and safety of oral corticosteroids andolfactory training in the management of COVID-19-related loss of smell. Eur Arch Otorhinolaryngol. 2021;278(8):3113-17. doi: 10.1007/s00405-020-06520-8
2. Boscolo-Rizzo P, Borsetto D, Fabbris C, Spinato G, Frezza D, Menegaldo A, et al. Evolution of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19. JAMA Otolaryngol Head Neck Surg. 2020;146(8):729-732. doi: 10.1001/jamaoto.2020.1379
3. Tan BKJ, Han R, Zhao JJ, Tan NKW, Quah ESH, Tan CJ, et al. Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves. BMJ. 2022;378:e069503. doi:10.1136/bmj-2021-069503
4. Le Bon SD, Pisarski N, Verbeke J, Prunier L, Cavelier G, Thill MP, et al. Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients. Eur Arch Otorhinolaryngol. 2021;278(1):101-08. doi: 10.1007/s00405-020-06267-2
5. Vaira LA, Hopkins C, Petrocelli M, Lechien JR, Chiesa-Estomba CM, Salzano G, et al. Smell and taste recovery incoronavirus disease 2019 patients: a 60-day objective and prospective study. J Laryngol Otol. 2020;134(8):703-9. doi:10.1017/S0022215120001826
6. Huart C, Philpott C, Konstantinidis I, Altundag A, Whitcroft KL, Trecca EMC, et al. Comparison of COVID-19 and common cold chemosensory dysfunction. Rhinology. 2020;58(6):623-25. doi: 10.4193/Rhin20.251
7. Suzuki M, Saito K, Min W-P, Vladau C, Toida K, Itoh H, et al. Identification of viruses in patients with postviral olfactory dysfunction. Laryngoscope, 2017;117(2):272-77. doi:10.1097/01.mlg.0000249922.37381.1e
8. Hura N, Xie DX, Choby GW, Schlosser RJ, Orlov CP, Seal SM, et al. Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2020;10(9):1065-86. doi: 10.1002/alr.22624
9. Pinto JM, Wroblewski KE, Kern DW, Schumm LP, McClintock MK. Olfactory dysfunction predicts 5-year mortality in older adults. PLoS One. 2014;9(10):e107541. doi: 10.1371/journal.pone.0107541
10. Miwa T, Ikeda K, Ishibashi T, Motoo Y, Fujieda S, Kurono Y, et al. Clinical practice guidelines for the management of olfactory dysfunction: secondary publication. Auris Nasus Larynx. 2019;46(5):653-62. doi: 10.1016/j.anl.2019.04.002
11. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al.SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J 2020;382(12):1177-79. doi: 10.1056/NEJMc2001737
12. Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681-7. doi: 10.1038/s41591-020-0868-6
13. Hou Y, Okuda K, Edwards C, Martínez D, Asakura T, Dinnon K, et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell. 2020;182(2):429-46. doi:10.1016/j.cell.2020.05.042
14. Ziegler CG, Allon SJ, Nyquist SK, Mbano IM, Miao VN,Tzouanas CN, et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020;181(5):1016-1035. doi: 10.1016/j.cell.2020.04.035
15. Gallo O, Locatello LG, Mazzoni A, Novelli L, Annunziato F. The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARSCoV-2 infection. Mucosal Immunol. 2020;14(2):305-16. doi:10.1038/s41385-020-00359-2
16. Sommerstein R, Fux CA, Vuichard-Gysin D, Abbas M, Marschall J, Balmelli C, et al. Risk of SARS-CoV-2 transmission by aerosols, the rational use of masks, and protection of healthcare workers from COVID-19. Antimicrob Resist Infect Control. 2020;9:100. doi: 10.1186/s13756-020-00763-0
17. WHO Scientific Brief: Transmission of SARS-CoV-2: implications for infection prevention precautions. Geneva: World Health Organization; 2020. [acceso 10 de abril de 2021]. Disponible en: https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infectionprevention-precautions
18. Lechien JR, Chiesa-Estomba CM, Hans S, Barillari MR, Jouffe L, Saussez S. Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19. Ann. Intern. Med. 2020;173(8):672-75. doi: 10.7326/M20-2428
19. Boesveldt S, Postma EM, Boak D, Welge-Luessen A, Schopf V, Mainland, J, et al. Anosmia - A Clinical Review. Chemical Senses. 2017;42(7):513-23. doi: 10.1093/chemse/bjx025
20. Izquierdo-Domínguez A, Rojas-Lechuga MJ, Mullol J, Alobid I. Olfactory dysfunction during COVID-19 pandemic. Med Clin (Barc). 2020;155(9):403-408. English, Spanish. doi:10.1016/j.medcli.2020.06.006
21. Menni C, Valdes AM, Freidin MB, Sudre CH, Nguyen LH, Drew DA, et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. 2020;26(7):1037-40.doi: 10.1038/s41591-020-0916-2
22. Solomon IH, Normandin E, Bhattacharyya S, Mukerji SS, Keller K, Ali AS, et al. Neuropathological Features of Covid-19. The N Engl J Med. 2020;383(10):989-92. doi: 10.1056/NEJMc2019373
23. Brann DH, Tsukahara T, Weinreb C, Lipovsek M, Van den Berge K, Gong B, et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv. 2020;6(31):eabc5801. doi: 10.1126/sciadv.abc5801
24. Desai M, Oppenheimer J. The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical Practice. JACI. 2021;9(1):7-12. doi: 10.1016/j.jaip.2020.10.036
25. Whitcroft KL, Hummel T. Clinical Diagnosis and Current Management Strategies for Olfactory Dysfunction: A Review. JAMA Otolaryngol Head Neck Surg. 2019;145(9):846-53. doi:10.1001/jamaoto.2019.1728
26. Moein ST, Hahemian SMR, Mansourafshar B, Khorram-Tousi A, Tabarsi P, Doty RL. Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 2020;10(8):944-50. doi:10.1002/alr.22587
27. Sorokowska A, Drechsler E, Karwowski M, Hummel T.Effects of olfactory training: a meta-analysis. Rhinology 2017;55(1):17-26. doi: 10.4193/Rhin16.195
28. Kandemirli SG, Altundag A, Yildirim D, Tekcan Sanli DE, Saatci O. Olfactory Bulb MRI and Paranasal Sinus CT Findings in Persistent COVID-19 Anosmia. Acad Radiol. 2021;28(1):28-35. doi: 10.1016/j.acra.2020.10.006
29. Aragao M, Leal MC, Cartaxo Filho OQ. Anosmia in COVID-19 associated with injury to the olfactory bulbs evident on MRI.AJNR Am J Neuroradiol. 2020;41(9):1703-06. doi: 10.3174/ajnr.A6675
30. Galougahi MK, Ghorbani J, Bakhshayeshkaram M. Olfactory bulb magnetic resonance imaging in SARS-CoV-2-induced anosmia: the first report. Acad Radiol. 2020;27(6):892-93. doi:10.1016/j.acra.2020.04.002
31. Laurendon T, Radulesco T, Mugnier J. Bilateral transient olfactory bulbs edema during COVID-19-related
1. anosmia. Neurology. 2020;95(5):224-25. doi: 10.1212/WNL.0000000000009850
32. Politi LS, Salsano E, Grimaldi M. Magnetic resonance imaging alteration of the brain in a patient with coronavirus disease 2019(COVID-19) and anosmia. JAMA Neurol. 2020;77(8):1028-29. doi: 10.1001/jamaneurol.2020.2125
33. Doty RL. Treatments for smell and taste disorders: A critical review. Handb Clin Neurol. 2019;164:455-479. doi: 10.1016/B978-0-444-63855-7.00025-3
34. Scangas GA, Bleier BS. Anosmia: Differential Diagnosis, Evaluation, and Management. Am J Rhinol Allergy.2017;31(1):3-7. doi: 10.2500/ajra.2017.31.4403
35. Vaira LA, Deiana G, Fois AG, Pirina P, Madeddu G, De Vito A, et al. Objective evaluation of anosmia and ageusia inCOVID-19 patients: single-center experience on 72 cases.Head Neck. 2020;42(6):1252-8. doi: 10.1002/hed.26204
36. Cooper KW, Brann DH, Farruggia MC, Bhutani S, Pellegrino R, Tsukahara T, et al. COVID-19 and the chemical senses: supporting players take center stage. Neuron. 2020;107(2):219-33. doi: 10.1016/j.neuron.2020.06.032
37. Konstantinidis I, Tsakiropoulou E, Bekiaridou P, KazantzidouC, Constantinidis J. Use of Olfactory Training in Post-Traumatic and Postinfectious Olfactory Dysfunction. The Laryngoscope.2013;123(12):E85-90. doi: 10.1002/lary.24390
38. Pellegrino R, Han P, Reither N, Hummel T. Effectiveness of Olfactory Training on Different Severities of Posttraumatic Loss of Smell. The Laryngoscope. 2019;129(8):1737-43. doi:10.1002/lary.27832
39. Patel ZM. Olfactory Loss and Olfactory Training. JAMA Otolaryngol Head Neck Surg. 2021;147(9):840. doi: 10.1001/jamaoto.2021.1507
40. Pekala K, Chandra RK, Turner JH. Efficacy of olfactory training in patients with olfactory loss: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2016;6(3):299-307.doi: 10.1002/alr.21669
41. Lavinsky J, Kosugi EM, Baptistella E, Roithmann R, Dolci E, Ribeiro TK, et al. An update on COVID-19 for the otorhinolaryngologist - a Brazilian Association of Otolaryngology and Cervicofacial Surgery (ABORL-CCF) Position Statement. Braz J Otorhinolaryngol. 2020;86(3):273-80. doi: 10.1016/j.bjorl.2020.04.002
42. Walker A, Pottinger G, Scott A, Hopkin C. Anosmia and loss of smell in the era of covid-19. BMJ. 2020;370:m2808. doi:10.1136/bmj.m2808